'A new window on the brain' may inform drug development

Investigating the role of the cerebellum

Hospital achieved savings of $478,055

Mobile PET/CT, syngo.via for SPECT, and exclusive U.S. distro rights for Amyvid

Ga-68 PSMA has high rate of detection in patients with metastatic prostate tumors

Solia S ProMRI comes in three different lengths

Can contact emergency services, and features wheelchair-dedicated workouts

'We are planning state-wide suspension of sonography tests'

The surge to merge in the health care space continues

Warns of higher costs associated with developing new sources

Offloading $3 billion segment could be in the cards: report

Forgotten — but not gone

With GlucoCEST, researchers aim for safer imaging alternative

CMS issues update to payment policies and rates under IPPS

Promoting public-private partnerships for health care solutions

Limiting kidney exposure while maximizing tumor treatment

Method shows white matter abnormalities in patients

Contracts will not be altered but some are worried about the bottom line

Only 14 percent believe it reduces lung-cancer related deaths

Shows promise in pilot study

An up-close look at a booming industry

Often no symptoms of cardiac issues in these patients

New modalities push the envelope for care and research goals

There has been a renaissance of academic and commercial activity in artificial intelligence

May lead to a 34 percent lower risk of overall mortality

Lessons from the battlefield helped save the lives of victims

Study also points to major earnings disparity between men and women

$91 million investment made

Patients report no changes in urinary or sexual function

Research earns 'SNMMI Image of the Year' award

By 2019 that number is expected to rise to 23 percent

Announced at opening SNMMI plenary session

'The best test is one that patients will actually use'

PET and SPECT: the good, the bad and the future

Early results indicate reduced misplacement

First dedicated proton therapy center in Russia

For cervical, breast and prostate cancer research

70 percent of Americans don’t know what to do during an event

May lead to development of new treatment drugs

The following are just some of the products and services on display at SNMMI 2016